Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MEDPthis companyMedpace Holdings, Inc.	$664.41	35.91×	35.29×	6.4×	27.77×	-39.0%	30.1%	21.1%	17.8%	98.3%	67.9%	4.2%	0.3×	-0.63×	0×	0.74×	0.0%	8	8.08	3	B+
CRLCharles River Laboratories International, Inc.	$354.08	-69.99×	3.19×	2.51×	31.51×	-76.6%	30.5%	12.6%	-3.6%	-4.6%	8.4%	5.1%	0.97×	6.94×	4.74×	1.29×	0.0%	5	2.99	1	C-
FTREFortrea Holdings Inc.	$22.79	-1.6×	2.79×	0.58×	-3.09×	-197.3%	15.6%	-1.1%	-36.2%	-175.0%	-1.7%	5.6%	1.98×	-1.16×	-0.33×	0.98×	0.0%	5	0.78	1	C-
IQVIQVIA Holdings Inc.	$276.55	28.5×	5.96×	2.38×	18.02×	-24.1%	33.3%	13.4%	8.3%	20.9%	7.9%	5.3%	2.49×	4.83×	2.99×	0.75×	0.0%	8	2.27	3	B
Peer median	—	-1.6×	3.19×	2.38×	18.02×	-76.6%	30.5%	12.6%	-3.6%	-4.6%	7.9%	5.3%	1.98×	4.83×	2.99×	0.98×	0.0%	5	2.27	1	—